Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic pathogen that can transmit from dromedary camels to humans, causing severe pneumonia, with a 35% mortality rate. Vaccine candidates have been developed and tested in mice, camels, and humans. Previously, we developed a vaccine...

Full description

Bibliographic Details
Main Authors: Naif Khalaf Alharbi, Fahad Aljamaan, Haya A. Aljami, Mohammed W. Alenazi, Hind Albalawi, Abdulrahman Almasoud, Fatima J. Alharthi, Esam I. Azhar, Tlili Barhoumi, Mohammad Bosaeed, Sarah C. Gilbert, Anwar M. Hashem
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Vaccines
Subjects:
MVA
MERS-CoV
viral vector
vaccine
antibody
camel
Online Access:https://www.mdpi.com/2076-393X/10/8/1330

Internet

https://www.mdpi.com/2076-393X/10/8/1330

Similar Items